Gut Microbiota and the Hidden Side of Post-Bariatric Surgery Outcomes

Dr. Abhishek Katakwar, Associate Director, Bariatric & Metabolic Surgery, AIG Hospitals, Hyderabad, Telangana

Bariatric surgery is now widely recognized as the most effective long-term intervention for severe obesity, offering substantial and sustained weight loss along with marked improvements in metabolic conditions such as type 2 diabetes and dyslipidemia. Procedures such as laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy not only reduce body weight but also enhance insulin sensitivity, improve lipid profiles, and promote long-term cardiometabolic benefits through mechanisms involving gut hormones, bile acids, and changes in the intestinal microbiota.

However, despite these successes, post-surgical complications remain clinically significant. Abdominal pain is among the most common complaints, affecting up to half of patients, and may arise from identifiable causes such as gallstones, anastomotic ulcers, or internal herniation. In a substantial proportion of cases, pain remains unexplained and persists long-term, resembling irritable bowel syndrome.

Emerging evidence suggests that alterations in gut microbiota after surgery may contribute to both metabolic improvements and gastrointestinal symptoms. Changes in microbial diversity and metabolite production, particularly short-chain fatty acids and bile acid derivatives, may influence gut motility, inflammation, and visceral sensitivity.

Understanding the microbiota–gut–brain axis after bariatric surgery may help explain persistent symptoms and open new avenues for targeted therapies alongside metabolic benefits.

(Reference: de Louweren B, Nieuwdorp M, Gerdes VE. Abdominal Pain After Bariatric Surgery and the Role of the Gut: A Review. Diabetes Therapy. 2026 Feb 23:1-7. )